5.16BMarket Cap47.37P/E (TTM)
25.190High24.930Low58.84KVolume25.050Open24.810Pre Close1.47MTurnover0.07%Turnover Ratio67.85P/E (Static)205.39MShares25.25052wk High2.18P/B2.15BFloat Cap11.10052wk Low--Dividend TTM85.80MShs Float25.250Historical High--Div YieldTTM1.05%Amplitude8.750Historical Low25.038Avg Price1Lot Size
Life Time Stock Forum
Select biotech/pharma names showing strength following ESMO:
$Clovis Oncology (CLVS.US)$ +11.3%, $Cardiff Oncology (CRDF.US)$ +9%, $Immatics (IMTX.US)$ +8.3%, $IDEAYA Biosciences (IDYA.US)$ +8%, $Lyra Therapeutics (LYRA.US)$ +5.7%, $POINT Biopharma (PNT.US)$ +5.7%, $Edgewise Therapeutics (EWTX.US)$ +4.7%, $Concert Pharmaceuticals (CNCE.US)$ +3.6%, $Deciphera Pharmaceuticals (DCPH.US)$ +3.2%, $Veracyte (VCYT.US)$ +2.6%, $SpringWorks Therapeutics (SWTX.US)$ +2.3%, ...
No comment yet